Wharton’s Jelly stem cells: Future clinical applications
Authors:
- K.J. CetruloKCK.J. Cetrulo
- C.L. CetruloCCC.L. Cetrulo
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The bioethics of stem cell research and therapyJournal of Clinical Investigation, 2010
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial InfarctionJACC, 2009
- Effects of Ectopic Nanog and Oct4 Overexpression on Mesenchymal Stem CellsStem Cells and Development, 2009
- Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic CancerCancer Research, 2009
- The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells in vitroImmunology, 2009
- Transplantation of Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly after Complete Transection of the Rat Spinal CordPLOS ONE, 2008
- Islet-Like Clusters Derived from Mesenchymal Stem Cells in Wharton's Jelly of the Human Umbilical Cord for Transplantation to Control Type 1 DiabetesPLOS ONE, 2008
- Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell PopulationStem Cells, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006